[18F]Flumazenil binding to central benzodiazepine receptor studies by PET. - Quantitative analysis and comparisons with [11C]flumazenil(307 views) Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, Farde L
Psychiatric Section, Department of Clinical Neuroscience Karolinska Institute, SE-17176 Stockholm, Sweden
AstraZeneca R and D, SE-15185 Södertälje, Sweden
Division of Functional Imaging, Department of Sensory, Integrative Medicine. Niigata University Graduate School of Medicine and Dental Sciences, Asahimachi-dori Niigata, 951-8510, Japan
Laboratory of Radiochemistry, Department of Chemistry, University of Helsinki, Finland
Institute of Human Brain, Russian Academy of Science, St. Petersburg, Russian Federation
References: Abadie, P., Baron, J.C., Bisserbe, J.C., Boulenger, J.P., Rioux, P., Travere, J.M., Barre, L., Zarifian, E., Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography (1992) Eur. J. Pharmacol., 213, pp. 107-11
Akaike, H., A new look at the statistical model identification (1974) IEEE Trans. Automat. Contr., AC-19, pp. 716-723
Bergstrom, M., Boethius, J., Eriksson, L., Greitz, T., Ribbe, T., Widen, L., Head fixation device for reproducible position alignment in transmission CT and positron emission tomography (1981) J. Comput. Assist. Tomogr., 5, pp. 136-141
Beuthien-Baumann, B., Holthoff, V.A., Rudolf, J., Functional imaging of vegetative state applying single photon emission tomography and positron emission tomography (2005) Neuropsychol. Rehabil., 15, pp. 276-282
Blomqvist, G., Pauli, S., Farde, L., Eriksson, L., Persson, A., Halldin, C., Maps of receptor binding parameters in the human brain-a kinetic analysis of PET measurements (1990) Eur. J. Nucl. Med., 16, pp. 257-265
Caceci, M.S., Cacheris, W.P., Fitting curves to data, the Simplex algorithm is the answer (1984) BYTE, 9, pp. 340-362
Carson, R.E., Parameter estimation in positron emission tomography (1986) Positron Emission Tomography. Principles and Applications for the Brain and Heart, pp. 347-390. , Phelps M.E., Mazziota J.C., and Schelbert H.R. (Eds), Raven Press, New York
Delforge, J., Pappata, S., Millet, P., Samson, Y., Bendriem, B., Jobert, A., Crouzel, C., Syrota, A., Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol (1995) J. Cereb. Blood Flow Metab., 15, pp. 284-300
Farde, L., Ito, H., Swahn, C.G., Pike, V.W., Halldin, C., Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man (1998) J. Nucl. Med., 39, pp. 1965-1971
Friston, K.J., Statistical parametric mapping (1994) Functional Neuroimaging, pp. 79-93. , Thatcher R.W., Hallett M., Zeffiro T., John E.R., and Huerta M. (Eds), Academic Press, San Diego
Ginovart, N., Meyer, J.H., Boovariwala, A., Hussey, D., Rabiner, E.A., Houle, S., Wilson, A.A., Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain (2006) J. Cereb. Blood Flow Metab., 26, pp. 330-344
Gründer, G., Siessmeier, T., Lange-Asschenfeldt, C., Vernaleken, I., Buchholz, H.G., Stoeter, P., Drzezga, A., Bartenstein, P., [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors (2001) Eur. J. Nucl. Med., 28, pp. 1463-1470
Gunn, R.N., Sargent, P.A., Bench, C.J., Rabiner, E.A., Osman, S., Pike, V.W., Hume, S.P., Lammertsma, A.A., Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET (1998) NeuroImage, 8, pp. 426-440
Halldin, C., Swan, C.-G., Farde, L., Sedvall, G., Radioligand disposition and metabolism - key information in early drug development (1995) PET for Drug Development and Evaluation, pp. 55-65. , Comar D. (Ed), Kluwer, Dordrecht
Hammers, A., Flumazenil positron emission tomography and other ligands for functional imaging (2004) Neuroimaging Clin. N. Am., 14, pp. 537-551
Huang, S.C., Barrio, J.R., Phelps, M.E., Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches (1986) J. Cereb. Blood Flow Metab., 6, pp. 515-521
Innis, R.B., Cunningham, V.J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R.N., Holden, J., Carson, R.E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J. Cereb. Blood Flow Metab., 27, pp. 1533-1539
Koeppe, R.A., Holthoff, V.A., Frey, K.A., Kilbourn, M.R., Kuhl, D.E., Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography (1991) J. Cereb. Blood Flow Metab., 11, pp. 735-744
Lammertsma, A.A., Hume, S.P., Simplified reference tissue model for PET receptor studies (1996) NeuroImage, 4, pp. 153-158
Lammertsma, A.A., Bench, C.J., Hume, S.P., Osman, S., Gunn, K., Brooks, D.J., Frackowiak, R.S., Comparison of methods for analysis of clinical [11C]raclopride studies (1996) J. Cereb. Blood Flow Metab., 16, pp. 42-52
Landaw, E.M., DiStefano III, J.J., Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations (1984) Am. J. Physiol., 246, pp. R665-R677
Lingford-Hughes, A., Wilson, S.J., Cunningham, V.J., Feeney, A., Stevenson, B., Brooks, D.J., Nutt, D.J., GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study (2005) Psychopharmacology, 180, pp. 595-606
Litton, J.E., Neiman, J., Pauli, S., Farde, L., Hindmarsh, T., Halldin, C., Sedvall, G., PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls (1993) Psychiatry Res., 50, pp. 1-13
Logan, J., Wolf, A.P., Shiue, C.Y., Fowler, J.S., Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers (1987) J. Neurochem., 48, pp. 73-83
Logan, J., Fowler, J.S., Volkow, N.D., Wolf, A.P., Dewey, S.L., Schlyer, D.J., MacGregor, R.R., Gatley, S.J., Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects (1990) J. Cereb. Blood Flow Metab., 10, pp. 740-747
Lundberg, J., Odano, I., Olsson, H., Halldin, C., Farde, L., Quantification of 11C-MADAM binding to the serotonin transporter in the human brain (2005) J. Nucl. Med., 46, pp. 1505-1515
Marquardt, D.W., An algorithm for least-squares estimation of nonlinear parameters (1963) Soc. Indust. Appl. Math., 11, pp. 431-441
Maziere, M., Hantraye, P., Prenant, C., Sastre, J., Comar, D., Synthesis of ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1, 4]benzodiazepine-3-carboxylate (Ro 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography (1984) Int. J. Appl. Radiat. Isot., 35, pp. 973-976
Meyer, M., Koeppe, R.A., Frey, K.A., Foster, N.L., Kuhl, D.E., Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease (1995) Arch. Neurol., 52, pp. 314-317
Millet, P., Graf, C., Buck, A., Walder, B., Ibánez, V., Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters (2002) NeuroImage, 17, pp. 928-942
Mintun, M.A., Raichle, M.E., Kilbourn, M.R., Wooten, G.F., Welch, M.J., A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography (1984) Ann. Neurol., 15, pp. 217-227
Moerlein, S.M., Perlmutter, J.S., Binding of 5-(2′-[18F]fluoroethyl) flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography (1992) Eur. J. Pharmacol., 218, pp. 109-115
Nagren, K., Halldin, C., Methylation of amide and thiol functions with [11C]methyl triflate, as exemplified by [11C]NMSP, [11C]flumazenil and [11C]methionine (1998) J. Label. Compd. Radiopharm., 41, pp. 831-841
Odano, I., Farde, L., Savic, I., Ciumas, C., Krasikova, R., Airaksinen, A., Gulyas, B., Halldin, C., Central benzodiazepine receptor mapping with [18F]flumazenil and PET-the first study in human brain (2006) J. Nucl. Med., 47, pp. 13p-14p
Pappata, S., Samson, Y., Chavoix, C., Prenant, C., Maziere, M., Baron, J.C., Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET (1988) J. Cereb. Blood Flow Metab., 8, pp. 304-313
Persson, A., Ehrin, E., Eriksson, L., Farde, L., Hedstrom, C.C., Litton, J.E., Mindus, P., Sedvall, G., Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography (1985) J. Psychiat. Res., 19, pp. 609-622
Persson, A., Pauli, S., Halldin, C., Stone-Elander, S., Farde, L., Sjogren, I., Sedvall, G., Saturation analysis of specific 11C Ro 15-1788 binding to the human neocortex using positron emission tomography (1989) Hum. Psychopharmacol., 4, pp. 21-31
Price, J.C., Mayberg, H.S., Dannals, R.F., Wilson, A.A., Ravert, H.T., Sadzot, B., Rattner, Z., Frost, J.J., Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil (1993) J. Cereb. Blood Flow Metab., 13, pp. 656-667
Ryzhikov, N.N., Seneca, N., Krasikova, R.N., Gomzina, N.A., Shchukin, E., Fedorova, O.S., Vassiliev, D.A., Halldin, C., Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography (2005) Nucl. Med. Biol., 32, pp. 109-116
Sadato, N., Tsuchida, T., Nakaumra, S., Waki, A., Uematsu, H., Takahashi, N., Hayashi, N., Ishii, Y., Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours (1998) Eur. J. Nucl. Med., 25, pp. 559-564
Savic, I., Persson, A., Roland, P., Pauli, S., Sedvall, G., Widen, L., In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci (1988) Lancet, 2, pp. 863-866
Schwarz, G., Estimating the dimension of a model (1978) Ann. Statist., 6, pp. 461-464
Turner, M.R., Osei-Lah, A.D., Hammers, A., Al-Chalabi, A., Shaw, C.E., Andersen, P.M., Brooks, D.J., Mills, K.R., Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS (2005) J. Neurol. Neurosurg Psychiatry, 76, pp. 1279-1285
van Rij, C.M., Huitema, A.D., Swart, E.L., Greuter, H.N., Lammertsma, A.A., van Loenen, A.C., Franssen, E.J., Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations (2005) Br. J. Clin. Pharmacol., 60, pp. 477-485
Wienhard, K., Dahlbom, M., Eriksson, L., Michel, C., Bruckbauer, T., Pietrzyk, U., Heiss, W.D., The ECAT EXACT HR: performance of a new high resolution positron scanner (1994) J. Comput. Assist. Tomogr., 18, pp. 110-118
Wong, D.F., Gjedde, A., Wagner Jr., H.N., Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands (1986) J. Cereb. Blood Flow Metab., 6, pp. 137-146
Yamauchi, H., Kudoh, T., Kishibe, Y., Iwasaki, J., Kagawa, S., Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study (2005) J. Nucl. Med., 46, pp. 1973-1979
Yoon, Y.H., Jeong, J.M., Kim, H.W., Hong, S.H., Lee, Y.S., Kil, H.S., Chi, D.Y., Lee, M.C., Novel one-pot one-step synthesis of 2′-[(18)F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging (2003) Nucl. Med. Biol., 30, pp. 521-527
Zasadny, K.R., Wahl, R.L., Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction (1993) Radiology, 189, pp. 847-850
Caceci, M. S., Cacheris, W. P., Fitting curves to data, the Simplex algorithm is the answer (1984) BYTE, 9, pp. 340-362
Carson, R. E., Parameter estimation in positron emission tomography (1986) Positron Emission Tomography. Principles and Applications for the Brain and Heart, pp. 347-390. , Phelps M. E., Mazziota J. C., and Schelbert H. R. (Eds), Raven Press, New York
Friston, K. J., Statistical parametric mapping (1994) Functional Neuroimaging, pp. 79-93. , Thatcher R. W., Hallett M., Zeffiro T., John E. R., and Huerta M. (Eds), Academic Press, San Diego
Gr nder, G., Siessmeier, T., Lange-Asschenfeldt, C., Vernaleken, I., Buchholz, H. G., Stoeter, P., Drzezga, A., Bartenstein, P., [18F] Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors (2001) Eur. J. Nucl. Med., 28, pp. 1463-1470
Gunn, R. N., Sargent, P. A., Bench, C. J., Rabiner, E. A., Osman, S., Pike, V. W., Hume, S. P., Lammertsma, A. A., Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C] WAY-100635 for PET (1998) NeuroImage, 8, pp. 426-440
Huang, S. C., Barrio, J. R., Phelps, M. E., Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches (1986) J. Cereb. Blood Flow Metab., 6, pp. 515-521
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Carson, R. E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J. Cereb. Blood Flow Metab., 27, pp. 1533-1539
Koeppe, R. A., Holthoff, V. A., Frey, K. A., Kilbourn, M. R., Kuhl, D. E., Compartmental analysis of [11C] flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography (1991) J. Cereb. Blood Flow Metab., 11, pp. 735-744
Lammertsma, A. A., Hume, S. P., Simplified reference tissue model for PET receptor studies (1996) NeuroImage, 4, pp. 153-158
Landaw, E. M., DiStefano III, J. J., Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations (1984) Am. J. Physiol., 246, pp. R665-R677
Litton, J. E., Neiman, J., Pauli, S., Farde, L., Hindmarsh, T., Halldin, C., Sedvall, G., PET analysis of [11C] flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls (1993) Psychiatry Res., 50, pp. 1-13
Marquardt, D. W., An algorithm for least-squares estimation of nonlinear parameters (1963) Soc. Indust. Appl. Math., 11, pp. 431-441
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., Welch, M. J., A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography (1984) Ann. Neurol., 15, pp. 217-227
Moerlein, S. M., Perlmutter, J. S., Binding of 5- (2 - [18F] fluoroethyl) flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography (1992) Eur. J. Pharmacol., 218, pp. 109-115
Price, J. C., Mayberg, H. S., Dannals, R. F., Wilson, A. A., Ravert, H. T., Sadzot, B., Rattner, Z., Frost, J. J., Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C] flumazenil (1993) J. Cereb. Blood Flow Metab., 13, pp. 656-667
Ryzhikov, N. N., Seneca, N., Krasikova, R. N., Gomzina, N. A., Shchukin, E., Fedorova, O. S., Vassiliev, D. A., Halldin, C., Preparation of highly specific radioactivity [18F] flumazenil and its evaluation in cynomolgus monkey by positron emission tomography (2005) Nucl. Med. Biol., 32, pp. 109-116
Turner, M. R., Osei-Lah, A. D., Hammers, A., Al-Chalabi, A., Shaw, C. E., Andersen, P. M., Brooks, D. J., Mills, K. R., Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS (2005) J. Neurol. Neurosurg Psychiatry, 76, pp. 1279-1285
van Rij, C. M., Huitema, A. D., Swart, E. L., Greuter, H. N., Lammertsma, A. A., van Loenen, A. C., Franssen, E. J., Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations (2005) Br. J. Clin. Pharmacol., 60, pp. 477-485
Wong, D. F., Gjedde, A., Wagner Jr., H. N., Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands (1986) J. Cereb. Blood Flow Metab., 6, pp. 137-146
Yoon, Y. H., Jeong, J. M., Kim, H. W., Hong, S. H., Lee, Y. S., Kil, H. S., Chi, D. Y., Lee, M. C., Novel one-pot one-step synthesis of 2 - [(18) F] fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging (2003) Nucl. Med. Biol., 30, pp. 521-527
Zasadny, K. R., Wahl, R. L., Standardized uptake values of normal tissues at PET with 2- [fluorine-18] -fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction (1993) Radiology, 189, pp. 847-850
[18F]Flumazenil binding to central benzodiazepine receptor studies by PET. - Quantitative analysis and comparisons with [11C]flumazenil
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(730 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote